Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature Gurhan.

Slides:

Advertisements

Similar presentations

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Advertisements

The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.

How do psychological variables influence coping strategies in inflammatory bowel disease? Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,

Serta Kılınçalp, Akif Altınbaş, Ömer Başar, Murat Deveci, Osman Yüksel

Primary biliary cirrhosis

Does the endoscopic appearance of the ileocecal valve suggest the severity of Crohn's disease in the terminal ileum? Tamás Molnár, Klaudia Farkas, Ferenc.

Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease Giammarco Mocci, Manuela Marzo, Alfredo Papa, Alessandro.

Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease—what is the role of anti-TNF antibody?

Concurrent small bowel adenocarcinoma and carcinoid tumor in Crohn's disease — Case report and literature review Doron Boltin, Zohar Levi, Marisa Halpern,

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

YouTube® and inflammatory bowel disease

A case report: Ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis Urpo Kinnunen,

Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out? Christian Jakobsen, Vibeke Wewer, Frederikke Urne,

Liver abscess of the caudate lobe due to Staphylococcus aureus in an ulcerative colitis patient: First case report Andreia Albuquerque, Fernando Magro,

Ineffectiveness of infliximab therapy in severe infantile Crohn's disease Nuray Uslu, Yusuf Usta, Inci Nur Saltik-Temizel, Hulya Demir, Figen Gürakan,

Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis Vincent Billioud, Alexander C. Ford,

High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference Airi Jussila, Lauri J. Virta, Veikko Salomaa,

Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD) Mariam Aguas, Vicente Garrigues,

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

A. J. Walsh, M. Weltman, D. Burger, S. Vivekanandarajah, S. Connor, M

Anterior ischemic optic neuropathy in a patient with Crohn's disease and aberrant MTHFR and GPIIIa gene variants T. Felekis, K.H. Katsanos, C.D. Zois,

Serum prohepcidin levels in chronic inflammatory bowel diseases

Oral tacrolimus for pediatric steroid-resistant ulcerative colitis

Hemophagocytic syndrome in a child with severe Crohn's disease and familial Mediterranean fever Nuray Uslu, Hulya Demir, Gunay Balta, Inci N Saltik-Temizel,

Charlotte de Bie, Angelika Kindermann, Johanna Escher

N. Kjaersgaard Nielsen, V. Wewer, L. Skafte, A. Paerregaard

Hemophagocytic syndrome in a child with severe Crohn's disease and familial Mediterranean fever Nuray Uslu, Hulya Demir, Gunay Balta, Inci N Saltik-Temizel,

Endothelial function and cardiovascular risk in active inflammatory bowel diseases Mariabeatrice Principi, Mario Mastrolonardo, Pietro Scicchitano, Michele.

Fatal Colonic Perforation in a Pregnant with Behçet's Disease

Filiform polyposis associated with sigmoid diverticulitis in a patient without inflammatory bowel disease Hyun-Soo Kim, Kil Yeon Lee, Youn Wha Kim Journal.

Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population- based cohort followed for ten years May-Bente Bengtson, Camilla.

Public awareness of Crohn's disease and ulcerative colitis: A national survey Sieglinde Angelberger, Harald Vogelsang, Gottfried Novacek, Wolfgang Miehsler,

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

B. Sicilia, F. Arribas, J. Nerín, C. López Miguel, R. Vicente, F

Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out? Christian Jakobsen, Vibeke Wewer, Frederikke Urne,

Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases Danuta Owczarek,

Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease Gord Blackhouse, Nazila Assasi,

Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature Dana Duricova, Johan Burisch,

Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis Thomas W. Lee, Michael.

Gastrointestinal basidiobolomycosis in a child; an unusual fungal infection mimicking fistulising Crohn's disease Omar I. Saadah, Mohammad F. Farouq,

Paula Borralho, Ana Vieira, João Freitas, Paula Chaves, Jorge Soares

Clinical trials in luminal Crohn's disease: A historical perspective

M. Chaparro, P. Martínez-Montiel, M. Van Domselaar, F. Bermejo, J. L

Xian-rui Wu, Saurabh Mukewar, Ravi P. Kiran, Feza H

The usefulness of factor XIII levels in Crohn's disease

Genetic variants in autophagy-related genes and granuloma formation in a cohort of surgically treated Crohn's disease patients Marko Brinar, Séverine.

Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis Niels Teich, Tobias Klugmann Journal of.

Seth Lipka, Seymour Katz, Lev Ginzburg Journal of Crohn's and Colitis

Osteoporosis in inflammatory bowel disease

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis M. De Vos, O. Dewit, G. D'Haens,

Pediatric pulmonary Crohn's disease: More frequent than expected

Suppurative granulomatous inflammation in the ileo-anal pouch

Ulrich Bonse-Geuking, Michael Kraus Journal of Crohn's and Colitis

Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome

Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation Sjoerd F. Bakker,

Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease Gord Blackhouse, Nazila Assasi,

A case report: Ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis Urpo Kinnunen,

Fernando Fernández-Bañares, Antonio Salas, Maria Esteve

Subrata Ghosh, Benjamin Pariente, Diane R

Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA- based protocol in UK subjects with inflammatory bowel disease suitable.

Does active smoking really influence the course of Crohn's disease

Genotyping should be considered the primary choice for pre-treatment evaluation of thiopurine methyltransferase function Ulf Hindorf, Malin Lindqvist.

Yinghong Wang, Hua Gong, Rocio Lopez, Lei Lian, Ravi P. Kiran, Edy E

Surgical management of gluteal metastatic cutaneous Crohn's disease

Complete remission of a primary rectal lymphoma on ulcerative colitis, after withdrawal of azathioprine and infliximab Antonio López San Román, Manuel.

Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis S.D. McLaughlin, A. Culkin,

Bowel sonography in occlusive Crohn's disease

Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors Anilga Moradkhani, Linda.

Figure 1 Approximate timeline contrasting major historical events in the understanding of ulcerative colitis (red) and ... Figure 1 Approximate timeline.

Volume 151, Issue 4, Pages (October 2016)

Presentation transcript:

Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature Gurhan Sisman, Yusuf Erzin, Kadir Bal Journal of Crohn's and Colitis Volume 7, Issue 9, Pages e397-e398 (October 2013) DOI: 10.1016/j.crohns.2013.03.003 Copyright © 2013 European Crohn's and Colitis Organisation Terms and Conditions

Figure 1 The course of liver enzymes under IFX+AZA Tx (ULN: upper limit of normal). Journal of Crohn's and Colitis 2013 7, e397-e398DOI: (10.1016/j.crohns.2013.03.003) Copyright © 2013 European Crohn's and Colitis Organisation Terms and Conditions

Figure 2 Inflammatory infiltrates in portal areas with irregular bile duct epithelium and granuloma formation (arrowheads) (HEX200). Journal of Crohn's and Colitis 2013 7, e397-e398DOI: (10.1016/j.crohns.2013.03.003) Copyright © 2013 European Crohn's and Colitis Organisation Terms and Conditions